Rofecoxib, valdecoxib and celecoxib are associated with increased risks of myocardial infarction (MI) in patients with rheumatic disease

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1179, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Celecoxib: increased risk of myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1528, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Microalbuminuria Is Associated with Increased Risk of Death in Patients with Myocardial Infarction

By  

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 305-309

Karger

Access to resources Recommend Favorite

Factors associated with celecoxib, rofecoxib use in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite